Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Management of cancer Stories

2013-11-05 10:55:56

Study confirms that vascular normalization is the way these drugs improve patient survival Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, Massachusetts General Hospital (MGH) researchers report, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their...

2013-11-05 08:34:44

Current Medical Research & Opinion Publishes Positive Decision Impact Study Demonstrating Significant Impact on Colon Cancer Treatment Recommendations REDWOOD CITY, Calif., Nov. 5, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Current Medical Research & Opinion (CMRO) published positive results from the Partnership for Health Analytic Research (PHAR) clinical utility analysis of the Oncotype DX(®) colon cancer test, demonstrating that use of the...

2013-11-04 08:27:39

TUBINGEN, Germany, and NEW YORK, Nov. 4, 2013 /PRNewswire/ -- The non-profit Cancer Research Institute (CRI) and Ludwig Cancer Research (Ludwig), and CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that they will collaborate to enable clinical testing of novel cancer immunotherapy treatment options. Amplifying the immune system's ability to recognize, attack,...

2013-11-01 11:27:07

University of Colorado Cancer Center researchers used data from 4,276 cases of male breast cancer and 718,587 cases of female breast cancer to show that the disease is treated differently in men than in women. Specifically, male breast cancer is treated with mastectomy more often than female breast cancer, and in cases in which locally advanced female breast cancer is commonly treated with radiation, the treatment is less used in the male disease. Results are published in this month’s issue...

2013-10-31 08:29:21

ST. LOUIS, Oct. 31, 2013 /PRNewswire/ -- It makes sense that children and teens undergoing pediatric cancer treatment miss some school. There are days when they don't have the energy to keep up with their homework, and days when they can't go to school at all. Sometimes they might make it to class, only to feel listless and unable to concentrate. Existing learning disabilities may not get enough attention, and extra-curricular activities might have to be sidelined. But there's a lot...

2013-10-30 23:27:16

Personalized immunotherapy vaccine developed by Perseus PCI offers breakthrough, non-toxic treatment for cancer patients that uses the body's own cells to attack tumors and turn off the engine of cancer inside the body. Austin, TX (PRWEB) October 30, 2013 Despite billions of dollars spent, thousands of clinical trials conducted and hundreds of new pharmaceutical drugs launched, the 50+ year war on cancer has resulted in few victories. Pioneering biomedical scientists at Perseus PCI...

2013-10-30 10:24:33

Intervention doubled palliative care consultations; lowered in-hospital mortality and hospital readmission rates A pilot initiative conducted at Mount Sinai Hospital offers compelling evidence that establishing standardized criteria for calling a palliative care consultation improves the quality of care for patients hospitalized with advanced cancer. The investigators saw improvements in the use of hospice services, inpatient mortality, and hospital readmissions among patients offered the...

2013-10-30 08:30:54

Proceeds to Advance Multiple Next-Generation Cancer Immunotherapy Product Candidates SEATTLE and SAN FRANCISCO, Oct. 30, 2013 /PRNewswire/ -- Immune Design, a biotechnology company focused on the development of novel immune-based therapies for cancer and other chronic conditions, today announced it has closed a Series C financing totalling up to $49 million. This Series C round includes an upfront investment of $32.5 million, with the right of the syndicate to invest an additional $16.5...

2013-10-28 08:28:40

--Pilot Study Results Demonstrate the Feasibility of Using Sputum Samples and the Cell-CT Platform to Non-Invasively Detect the Presence or Absence of Lung Cancer-- SYDNEY and PHOENIX, Oct. 28, 2013 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today reported clinical data showing that its automated 3D cell imaging platform, the Cell-CT(TM), can detect lung cancer in sputum samples with high...

2013-10-27 23:00:55

May Be Able to Recreate Conditions That Keep Cancer Cells from Growing after They Have Spread New York, NY (PRWEB) October 27, 2013 Oncologists have long puzzled over the fact that after cancer treatment, single cancer cells that are dispersed throughout the body – so-called disseminated tumor cells – are quick to grow and form secondary tumors called metastases in certain organs, while in other organs they metastasize more slowly, sometimes decades later. Such is the case with head...